Selenium-Binding Protein 1 (SELENBP1) as Biomarker for Adverse Clinical Outcome After Traumatic Spinal Cord Injury

Introduction: Traumatic spinal cord injury (TSCI) presents a diagnostic challenge as it may have dramatic consequences for the affected patient. Additional biomarkers are needed for improved care and personalized therapy. Objective: Serum selenium binding protein 1 (SELENBP1) has been detected in my...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Front Neurosci
Asıl Yazarlar: Seelig, Julian, Heller, Raban Arved, Haubruck, Patrick, Sun, Qian, Klingenberg, Georg Jochen, Hackler, Julian, Crowell, Helena Lucia, Daniel, Volker, Moghaddam, Arash, Schomburg, Lutz, Biglari, Bahram
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Frontiers Media S.A. 2021
Konular:
Neuroscience
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC8204909/
https://ncbi.nlm.nih.gov/pubmed/34140879
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fnins.2021.680240
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller